Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Happy New Year from Diabetes in Control
We welcome in a new year and take a last look back at 2021 as we count down our most popular articles from the second half of the year.
Letter from the Editor
Hopefully, you were able to get a little break during the past week, and are recharged for 2022. As we mentioned in our last issue, we wanted to share the most-read features of 2021.
This week’s newsletter has the best of July through December. If you did not get a chance to read the best of the first half of 2021, click here.
Happy New Year from the staff at Diabetes in Control.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Best of 2021, Part 2
July
The GRADE Study is the most comprehensive study comparing multiple diabetic medications to assess efficacy in type 2 diabetes. So which drug therapy reigned supreme?
August
Evaluating the discordance between laboratory and continuous glucose monitoring estimated HbA1c.
September
A recent study looked at how different diets can affect blood glucose levels in patients with type 1 diabetes.
October
By Sheri Colberg, PhD
In the recent past, we discussed how to know if joint problems (e.g., overuse injuries) are due to being active, aging, or diabetes, but let’s focus on aging by itself this time around. Of course, we’d all love to slow down normal aging or even reverse some aspects of it, but is that even possible?
November
Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.
December
Could cannabis and/or CBD usage have an impact on type 2 diabetes, for good or ill?